While Kansas City Research Institute does not have any currently enrolling HCC trials at this time. Please complete a Patient ROI form, and our staff will contact you when something becomes available.

 

Key patient eligibility criteria for HCC Studies include:

  • Patients between 18 and 80 years of age (inclusive)
  • Diagnosis or suspected HCC
  • Inadequate response, loss of response, or intolerance to prior treatment
  • Life expectancy >3 months
  • No other primary cancers
  • Willing to travel to the site for study visits.